Aquila Healthcare Limited, a subsidiary of Aquila Group Holdings, was established in early 2020 to contribute to the global fight against the COVID-19 pandemic. Helmed by long-time Hong Kong resident Sophie Martineau, the company is driven by an unwavering social responsibility to make a positive contribution to global anti-pandemic efforts and to broaden access to life-saving medical devices and protective equipment. It has successfully developed and brought to market a robust portfolio of high-quality, reliable and cost-effective products for healthcare professionals – from medical-grade masks and protective gloves to lab equipment needed for testing and vaccinations, to diagnostic tools such as Rapid Antigen Tests – under the AQUILAVIE® brand. Going beyond conventional benchmarks of performance and quality, Aquila Healthcare meticulously manages each part of its supply chain to ensure absolute precision, quality and safety for each of its products; the integrity of each part of the process is independently verified and certified. It has undergone dramatic growth since its founding and has established offices in France, Italy, UK and the US serving both institutional and corporate clients; in early 2022, it launched its consumer business in Hong Kong and is seeking to further expand its reach to new markets and across new product categories.
